News

An Experimental Treatment Restores the Reparative Capacity of Stem Cells in Type 2 Diabetes

A team from the Sant Pau Research Institute (IR Sant Pau) has discovered that basic fibroblast growth factor (bFGF) can reverse the functional impairments of adipose tissue–derived stem cells in peo...

IR Sant Pau Participates in the National Meeting of ISCIII Platforms

Researchers and managers from the Institut de Recerca Sant Pau (IR Sant Pau) took part in the 3rd Conference of ISCIII Platforms for Support of R&D&I in Biomedicine and Health Sciences, held i...

La Marató de 3Cat Funds Four Research Projects Linked to IR Sant Pau to Advance Respiratory Disease Research

The latest edition of La Marató de 3Cat, dedicated to research on respiratory diseases, raised 10 million euros to support 36 projects led by 60 research teams across Catalonia. Respiratory diseases ...

Sant Pau Research Institute Welcomes Dr. Manel Esteller, ICREA Researcher, in a Strategic Commitment to Scientific Excellence

The Sant Pau Research Institute (IR Sant Pau) is incorporating Dr. Manel Esteller, an ICREA (Catalan Institution for Research and Advanced Studies) researcher and one of the world’s most renowned sc...

An International Review Highlights the Importance of Immune Metabolism in Heart Failure

Dr. Gemma Vilahur, head of the Molecular Pathology and Therapeutics of Atherothrombotic and Ischemic Diseases research group at the Institut de Recerca Sant Pau (IR Sant Pau) and member of the Steerin...